Head-to-head · WeighScore
California Trim Clinic vs Mevo Health
The verdict
Mevo Health takes it — 60.2/100 to 53.2/100.
Mevo Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Mevo Health (Mevo Health LLC, Delaware) is a direct-pay telehealth platform offering compounded semaglutide and tirzepatide in both injection and oral-tablet forms — a rare both-routes, both-molecules menu.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | California Trim Clinic | Mevo Health |
|---|---|---|
| WeighScore | 53.2/100 | 60.2/100 |
| Grade | C | C |
| Scorecard rank | #470 | #326 |
| Semaglutide | Not disclosed | $199/mo (all doses, compounded) |
| Tirzepatide | Not disclosed | $259/mo (all doses, compounded) |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Yes |
Graded #470 · C
Strengths
- Women's microdosing program specifically designed for perimenopause/menopause weight management
- 100% virtual nationwide telehealth; medications shipped discreetly to patients' homes
- 503A state-licensed compounding pharmacies with patient-specific prescription preparation
- $199 initial plan covers doctor consultation, telehealth setup, and full onboarding
- Ongoing 3-month treatment plans include compounded medication and licensed provider check-ins
Where it loses points
- Ongoing medication pricing not publicly disclosed — revealed only after $199 intake and provider approval
- No LegitScript certification or any other third-party accreditation visible on the site
- No physician names or clinical leadership disclosed publicly
- States served listed as 'nationwide' for telehealth but no state-by-state list published
- Microdose framing uses sub-clinical doses — potentially lower weight-loss efficacy than standard GLP-1 protocols
Graded #326 · C
Strengths
- LegitScript verification badge on multiple pages
- Publishes the FDA compounded-medication disclaimer
- Four named board-certified physicians disclosed (Wasef, Suppa, Sakla, Chikando)
- Both semaglutide and tirzepatide in injection and oral-tablet forms — rare in DTC
- Public entry-level pricing surfaced
Where it loses points
- States served not listed on any public page
- Pharmacy partners not named (only '503A U.S. compounding pharmacies' with unlabeled logos)
- No formal Medical Director role disclosed
- Only 'as low as' entry pricing shown — no per-dose itemization
- No SOC 2 certification claimed
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.